Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04289402 · ClinicalTrials.gov registry record · NA
Individualized Brain Stimulation to Improve Mobility in Alzheimer's Disease
A NA study of Aging and Alzheimer Dementia, sponsored by Hebrew SeniorLife.
- Active
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04289402: Active NA study of Aging and Alzheimer Dementia, sponsored by Hebrew SeniorLife.
NCT04289402 is a NA study of Aging and Alzheimer Dementia that is active but no longer recruiting, run by Hebrew SeniorLife. The registered enrollment target is 11 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04289402, a NA study of Aging and Alzheimer Dementia, is active but no longer recruiting, sponsored by Hebrew SeniorLife.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to conduct a pilot, randomized sham-controlled trials to determine the feasibility and effects of a 10-session personalized tDCS intervention targeting the left dorsolateral prefrontal cortex on cognitive function, dual task standing and walking, and other metrics of mobility in 24 older adults with mild AD living in supportive housing.
Primary Outcome
The number of residents that need to be screened in order to enroll one participant into the trial.
Conditions Studied
Interventions
- OTHER Active-Sham
- OTHER Personalized tDCS
Study Locations (1)
Massachusetts
- Hebrew Rehabilitation Center - Roslindale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-01-31 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the registry record for NCT04289402 still lists
NCT04289402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Active-Sham is the first listed.
NCT04289402 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04289402 about?
NCT04289402 is a clinical study titled "Individualized Brain Stimulation to Improve Mobility in Alzheimer's Disease". The objective of this study is to conduct a pilot, randomized sham-controlled trials to determine the feasibility and effects of a 10-session personalized tDCS intervention targeting the left dorsolateral prefrontal cortex on cognitive function, dual task standing and walking, and other metrics of m...
What is the current status of trial NCT04289402?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 11 participants. The study started on 2020-01-31. Estimated completion is 2026-01-31.
What conditions does trial NCT04289402 study?
This clinical trial studies the following conditions: Aging, Alzheimer Dementia, Presenile Alzheimer Dementia.
What interventions are being tested in trial NCT04289402?
The interventions under investigation include: Active-Sham (OTHER), Personalized tDCS (OTHER).
Who is sponsoring clinical trial NCT04289402?
This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04289402 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04289402's enrollment target sits among peer trials
11 257th of 262 higher than 6 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI